Metabolic Peptides

Retatrutide is a peptide-based compound designed to target metabolic pathways, primarily used for research in metabolic disorders like obesity and insulin resistance.

Retatrutide targets metabolic receptors to help regulate insulin sensitivity and fat metabolism, commonly used in metabolic disorder research.

Novopept's pre-filled injection pen ensures precise dosing and reliable delivery, designed for research use with a focus on accuracy and ease of application.

Retatrutide is not FDA-approved for clinical use and is intended for **research purposes only** under professional supervision.

Retatrutide is administered via subcutaneous injection using a pre-filled pen. The injection is typically given into fatty tissue just beneath the skin.

The frequency of use depends on the research protocol or clinical trial guidelines. It is usually administered as directed by healthcare professionals or research supervisors.

A prescription is not required for **research use**, but it is necessary for **clinical use**. Novopept products are for professional and research purposes only.

Minor side effects like temporary irritation at the injection site or mild fatigue may occur. Always consult the product leaflet or a healthcare provider for full information.

Retatrutide is not suitable for individuals with allergic reactions to peptides, pregnant women, or those with pre-existing metabolic conditions without proper medical supervision.

Each Novopept product comes with a unique authentication code that you can use to verify authenticity via our product verification system on the website.